IDEXX Laboratories, Inc. (IDXX)
Company Info
ISIN | US45168D1046 |
---|---|
CUSIP | 45168D104 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Highlights
Market Cap | $39.56B |
---|---|
EPS | $10.05 |
PE Ratio | 47.40 |
PEG Ratio | 4.75 |
Revenue (TTM) | $3.66B |
Gross Profit (TTM) | $2.00B |
EBITDA (TTM) | $1.21B |
Year Range | $372.50 - $583.39 |
Target Price | $604.62 |
Short % | 2.71% |
Short Ratio | 4.54 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: IDXX vs. ZTS, IDXX vs. EXAS, IDXX vs. VOO, IDXX vs. DXCM, IDXX vs. DHR, IDXX vs. EME, IDXX vs. VGT, IDXX vs. COST, IDXX vs. GOOGL, IDXX vs. AAPL
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in IDEXX Laboratories, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
IDEXX Laboratories, Inc. had a return of -13.60% year-to-date (YTD) and -3.24% in the last 12 months. Over the past 10 years, IDEXX Laboratories, Inc. had an annualized return of 22.78%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -13.60% | 6.30% |
1 month | -9.64% | -3.13% |
6 months | 12.12% | 19.37% |
1 year | -3.24% | 22.56% |
5 years (annualized) | 16.43% | 11.65% |
10 years (annualized) | 22.78% | 10.55% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -7.20% | 11.68% | -6.14% | |||||||||
2023 | -14.50% | -8.64% | 16.61% | 19.16% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
IDEXX Laboratories, Inc.(IDXX)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the IDEXX Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the IDEXX Laboratories, Inc. was 81.46%, occurring on Apr 18, 1997. Recovery took 1735 trading sessions.
The current IDEXX Laboratories, Inc. drawdown is 32.05%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-81.46% | Feb 6, 1996 | 304 | Apr 18, 1997 | 1735 | Mar 12, 2004 | 2039 |
-57.27% | Nov 16, 2007 | 256 | Nov 20, 2008 | 356 | Apr 23, 2010 | 612 |
-54% | Aug 6, 2021 | 301 | Oct 14, 2022 | — | — | — |
-37.13% | Feb 20, 2020 | 23 | Mar 23, 2020 | 32 | May 7, 2020 | 55 |
-35.36% | Nov 11, 1991 | 116 | Apr 27, 1992 | 142 | Nov 16, 1992 | 258 |
Volatility
Volatility Chart
The current IDEXX Laboratories, Inc. volatility is 5.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |